Masoumeh Rajabibazl

Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes

Walead Ebrahimizadeh, Seyed Latif Mousavi Gargari, Masoumeh Rajabibazl et al. · Applied Microbiology and Biotechnology · 2012 · 68 citations

Protective Anti-lps Nanobody, Pathogen Detection, Medicine +6

In Vivo Neutralization of Botulinum Neurotoxins Serotype E with Heavy-chain Camelid Antibodies (VHH)

Hamid Bakherad, Seyed Latif Mousavi Gargari, Iraj Rasooli et al. · Molecular Biotechnology · 2013 · 49 citations

Microbial Toxin, Toxinology, Pathogenesis +4

Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells

Gholamreza Taheripak, Salar Bakhtiyari, Masoumeh Rajabibazl et al. · Free Radical Biology and Medicine · 2013 · 46 citations

Skeletal Muscle Cells, Mitophagy, Signal Transduction +13

A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis

Fatemeh Araste, Walead Ebrahimizadeh, Iraj Rasooli et al. · Biotechnology Letters · 2013 · 35 citations

Nanomedicine, Novel Vhh Nanobody, Engineering +10

Camelid‐derived heavy‐chain nanobody against <i>Clostridium botulinum</i> neurotoxin E in <i>Pichia pastoris</i>

Roghayyeh Baghban, Seyed Latif Mousavi Gargari, Masoumeh Rajabibazl et al. · Biotechnology and Applied Biochemistry · 2014 · 34 citations

Engineering, Toxinology, Immunology +17